11 Amendments of Rebecca TAYLOR related to 2011/0429(COD)
Amendment 43 #
Proposal for a directive
Recital 6
Recital 6
(6) Numerous Union acts have been adopted since the adoption of Directive 2000/60/EC, which constitute emission control measures in accordance with Article 16 of that Directive for individual priority substances. Moreover, many environmental protection measures fall under the scope of other existing Union legislation. Therefore, priority should be given to implementing and revising existing instruments rather than establishing new controls. It would be appropriate to take a consistent policy approach regarding pharmaceutical substances, taking into consideration the full societal and medical implications, in full consultation with all relevant stakeholders. To this end, the Commission will produce a report with possible legislative proposals on the environmental effects of pharmaceutical substances for human use in waters and soils, under Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use1 and Regulation (EU) No. 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products2. The inclusion of a substance in Annex X to Directive 2000/60/EC is without prejudice to the application of the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. _______________ 1 OJ L 348, 31.12.2010, p. 74 2 OJ L 348, 31.12.2010, p. 1
Amendment 62 #
Proposal for a directive
Recital 17
Recital 17
(17) A new mechanism is needed to provide the Commission with targeted high-quality monitoring information on the concentration of substances in the aquatic environment, with a focus on emerging pollutants and substances for which available monitoring data are not of sufficient quality for the purpose of risk assessment. The new mechanism should facilitate the gathering of that information across Union river basins. In order to maintain the monitoring costs at reasonable levels, the mechanism should focus on a limited number of substances, included temporarily in a watch list, and a limited number of monitoring sites, but deliver representative data that are fit for the purpose of the Union prioritisation process. The list should be dynamic, to respond to new information on the potential risks posed by emerging pollutants and avoid monitoring substances for longer than necessary. Given the concerns raised in relation to Diclofenac, 17beta-estradiol and 17alpha-ethinylestradiol, the Commission is asked to prioritise undertaking scientific assessment of these three substances with a view to including them in a watch list, should that assessment justify inclusion. Any assessment of these three substances should include the potential economic and societal impact of their monitoring and restriction.
Amendment 128 #
Proposal for a directive
Article 2 – point 6
Article 2 – point 6
Directive 2008/105/EC
Article 8 b – paragraph 2 a (new)
Article 8 b – paragraph 2 a (new)
2 a. The Commission, within 12 months of the adoption of this directive, shall undertake scientific assessment of the following substances, to evaluate their suitability for inclusion in a watch list: i) Diclofenac ii) 17beta-estradiol iii) 17alpha-ethinylestradiol The Commission shall be assisted by the Committee established by Article 21(1) of Directive 2000/60/EC.
Amendment 135 #
Proposal for a directive
Article 2 – point 6
Article 2 – point 6
Directive 2008/105/EC
Article 8 b – paragraph 4 – subparagraph 1
Article 8 b – paragraph 4 – subparagraph 1
4. Member States shall monitor each substance in the watch list at selected representative monitoring stations over at least a 124-month period commencing within 36 months of its inclusion in the watch list.
Amendment 144 #
Proposal for a directive
Article 2 – point 6
Article 2 – point 6
Directive 2008/105/EC
Article 8 b – paragraph 4 – subparagraph 3
Article 8 b – paragraph 4 – subparagraph 3
In selecting the representative stations, the monitoring frequency and timing for each substance, Member States shall take into account the use patterns of the substance. The frequency of monitoring shall not be less than once pbe every 9 months to cover ysearsonal fluctuations.
Amendment 171 #
Proposal for a directive
Annex I – table – row 46
Annex I – table – row 46
Directive 2000/60/EC
Annex X – table – row 46
Annex X – table – row 46
Amendment 178 #
Proposal for a directive
Annex I – table – row 47
Annex I – table – row 47
Directive 2000/60/EC
Annex X – table – row 47
Annex X – table – row 47
Amendment 185 #
Proposal for a directive
Annex I – table – row 48
Annex I – table – row 48
Directive 2000/60/EC
Annex X – table – row 48
Annex X – table – row 48
Amendment 205 #
Proposal for a directive
Annex II – table – row 46
Annex II – table – row 46
Directive 2008/105/EC
Annex I – table – row 46
Annex I – table – row 46
Amendment 210 #
Proposal for a directive
Annex II – table – row 47
Annex II – table – row 47
Amendment 215 #
Proposal for a directive
Annex II – table – row 48
Annex II – table – row 48
Directive 2008/105/EC
Annex I – table – row 48
Annex I – table – row 48